Specialist expertise
Immunogenicity
Detecting, characterizing, and quantifying Anti-Drug Antibodies (ADAs) and Neutralizing Antibodies (NAbs).
The science
About this capability
Bioanalytical support for immunogenicity testing of therapeutics to detect, characterize, and quantify anti-drug antibodies (ADAs) and neutralizing antibodies (NAbs) that can impact the safety and efficacy of biologics, vaccines, and gene therapies.
Technical scope
- Tiered Testing Approach: Services typically follow a structured process: screening, confirmatory, titration, and neutralization analysis.
- Assay Development & Validation: Customization of ELISA, electrochemiluminescence (MSD), and cell-based assays.
- Cellular Immune Response: Evaluation of T-cell activation and other immunogenic potential assessments.
- Antibody Characterization: Identification of antibody isotype and specificity.
Let’s work together
The right expertise.
For your next step.
Talk with our scientific team about your requirements,
technical feasibility, and timelines.
What happens next
- Share your requirementsTell us about your research goals, scope, and timelines.
- Scientific consultationOur scientists review feasibility and discuss the best approach with you.
- Proposal and quoteReceive a clear proposal covering scope, deliverables, timelines, and cost.